Provided by Tiger Trade Technology Pte. Ltd.

Aquestive Therapeutics Inc.

4.66
-0.1600-3.32%
Volume:2.53M
Turnover:11.96M
Market Cap:584.60M
PE:-7.16
High:5.00
Open:5.00
Low:4.62
Close:4.82
52wk High:7.55
52wk Low:2.93
Shares:125.45M
Float Shares:115.00M
Volume Ratio:0.98
T/O Rate:2.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6512
EPS(LYR):-0.7836
ROE:148.50%
ROA:-29.20%
PB:-10.33
PE(LYR):-5.95

Loading ...

Aquestive Therapeutics' Potential Allergy Film Shows Improvements in Human Factors Study

MT Newswires Live
·
Aug 10

Aquestive Reports Positive Human Factors, PK Results for Anaphylm Epinephrine Sublingual Film in Healthy Volunteers

Reuters
·
Aug 10

Aquestive Posts Anaphylm Study Presentation on Investor Website

Reuters
·
Aug 10

Aquestive Therapeutics Announces Positive Topline Human Factors and Pharmacokinetic Study Results for Anaphylm™ (Dibutepinephrine) Sublingual Film

THOMSON REUTERS
·
Aug 10

Aquestive Therapeutics - Revised Anaphylm Packaging Reduces Median Pouch Opening Time to 3 Seconds

THOMSON REUTERS
·
Aug 10

Aquestive Therapeutics - Plans Anaphylm Nda Resubmission in Q3 2026

THOMSON REUTERS
·
Aug 10

Aquestive Therapeutics - Revised Instructions Reduce Incorrect Anaphylm Film Placement by over 80%

THOMSON REUTERS
·
Aug 10

Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET

GlobeNewswire
·
Jul 29

Aquestive Therapeutics CEO Daniel Barber Disposes of 25,000 Common Shares Worth $100,201.97

Reuters
·
Jul 18

Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism

GlobeNewswire
·
Jul 07

Aquestive Therapeutics files to sell 230,271 shares of common stock for holders

TIPRANKS
·
Jun 27

Aquestive Therapeutics - Files Prospectus for Resale of up to 230,271 Common Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Jun 27

Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST), Revolution Medicines (RVMD) and Bolt Biotherapeutics (BOLT)

TIPRANKS
·
Jun 25

Aquestive Therapeutics Director Julie Krop Disposes of 25,000 Common Shares for $125,392.5

Reuters
·
Jun 24

Aquestive Therapeutics CEO Daniel Barber sells 25,000 shares for $104,010

Reuters
·
Jun 17

Aquestive Therapeutics holds annual shareholder meeting

Reuters
·
Jun 11

Aquestive CEO Daniel Barber disposes of 8,257 shares worth $35,406.44

Reuters
·
May 19

Analysts Conflicted on These Healthcare Names: Aquestive Therapeutics (AQST), Pyxis Oncology (PYXS) and Biogen (BIIB)

TIPRANKS
·
May 15

Aquestive Therapeutics (AQST) Q1 Loss Per Share Narrows Challenging Bearish Narratives

Simply Wall St.
·
May 15

Analysts Are Bullish on These Healthcare Stocks: Aquestive Therapeutics (AQST), Monopar Therapeutics Inc (MNPR)

TIPRANKS
·
May 15